Home FDA labels d04a497f-2bc7-414e-a490-c6938647f1c0 Fluocinonide openFDA label record# This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)
Brand name Fluocinonide
Generic name FLUOCINONIDE
Manufacturer A-S Medication Solutions
Product type HUMAN PRESCRIPTION DRUG
SPL set ID ce75f0e1-c536-40ad-b77f-2e3ec29caeb7
SPL ID d04a497f-2bc7-414e-a490-c6938647f1c0
Version 12
Effective date 2024-11-06
Source export date 2026-10-12
Source partition 11
Source file https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key raw/openfda/drug-label/2026-10-12/a497e765d824a2e2aa9e88d5f0eea2aae9dcba363989e5f163395cda5c3c9dd8/drug-label-0011-of-0014.json.zip
Source manifest SHA-256 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run 20261013T011858Z
Imported at 2026-10-13 02:41:05 Harmonized routes table Harmonized routes TOPICAL
Harmonized identifier links# Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
Harmonized identifiers page 1 of 1 · 12 matching rows.
Adverse reactions cross-check# openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions sections page 1 of 1 · 2 matching rows.
adverse reactions ADVERSE REACTIONS The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: Burning Perioral dermatitis Itching Allergic contact dermatitis Irritation Maceration of the skin Dryness Secondary infection Folliculitis Skin atrophy Hypertrichosis Striae Acneiform eruptions Miliaria Hypopigmentation
adverse reactions table <table><col width="21%"/><col width="27%"/><tbody><tr><td valign="top" styleCode=" Botrule Toprule Lrule"><paragraph>Burning</paragraph></td><td valign="top" styleCode=" Botrule Toprule Lrule"><paragraph>Perioral dermatitis</paragraph></td></tr><tr><td valign="top" styleCode=" Botrule Lrule"><paragraph>Itching</paragraph></td><td valign="top" styleCode=" Botrule Lrule"><paragraph>Allergic contact dermatitis</paragraph></td></tr><tr><td valign="top" styleCode=" Botrule Lrule"><paragraph>Irritation</paragraph></td><td valign="top" styleCode=" Botrule Lrule"><paragraph>Maceration of the skin</paragraph></td></tr><tr><td valign="top" styleCode=" Botrule Lrule"><paragraph>Dryness</paragraph></td><td valign="top" styleCode=" Botrule Lrule"><paragraph>Secondary infection</paragraph></td></tr><tr><td valign="top" styleCode=" Botrule Lrule"><paragraph>Folliculitis</paragraph></td><td valign="top" styleCode=" Botrule Lrule"><paragraph>Skin atrophy</paragraph></td></tr><tr><td valign="top" styleCode=" Botrule Lrule"><paragraph>Hypertrichosis</paragraph></td><td valign="top" styleCode=" Botrule Lrule"><paragraph>Striae</paragraph></td></tr><tr><td valign="top" styleCode=" Botrule Lrule"><paragraph>Acneiform eruptions</paragraph></td><td valign="top" styleCode=" Botrule Lrule"><paragraph>Miliaria</paragraph></td></tr><tr><td valign="top" styleCode=" Botrule Lrule"><paragraph>Hypopigmentation</paragraph></td><td valign="top" styleCode=" Botrule Lrule"/></tr></tbody></table>
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.